400 Britons wait for an NHS liver - George Best's surgeon gives them to Greeks for 20,000 One of Britain's leading hospitals is giving NHS livers to private Greek and Cypriot patients even though there is a waiting list of 400 Britons in desperate need of donor organs.Health service watchdogs have now launched an inquiry...
Biliary complications more common in living donors of right liver lobe grafts NEW YORK (Reuters Health) - Living liver donors are significantly more likely to experience biliary complications when donating a right lobe than a left lobe, results of a study from Japan suggest.The researchers also found that...
Sea Life Safari Makes a Splash on Xbox LIVE Arcade (NewsRx.com) -- Sierra Online, a division of Vivendi Games, dives into the wonders of the deep with the launch of Sea Life Safari(TM) for Xbox LIVE(R) Arcade for the Xbox 360(R) video game and entertainment system from Microsoft.In...
Movetis advances cirrhosis drug to Phase IIb trial The randomized, double blind, placebo controlled, dose-titration study explored the safety, tolerability, pharmacokinetic profile and efficacy of M0002 in cirrhotic subjects with ascites and hypo- or normonatraemia.It was conducted in...
Beckman Coulter gets rights to HCV viral load test Beckman Coulter UK has acquired the rights from Siemens Healthcare Diagnostics to allow it to develop, manufacture and sell a quantitative viral load HCV blood test for use on the molecular diagnostic instrument it is currently developing.
Accidental fungus leads to promising cancer drug WASHINGTON (Reuters) - A drug developed using nanotechnology and a fungus that contaminated a lab experiment may be broadly effective against a range of cancers, U.S.researchers reported on Sunday.
The drug, called lodamin, was improved...
Accidental fungus leads to promising cancer drug By Maggie Fox, Health and Science Editor WASHINGTON, June 29 - A drug developed using nanotechnology and a fungus that contaminated a lab experiment may be broadly effective against a range of cancers, U.S.researchers reported on Sunday....
Male Breast Cancer - What You Should Know About! The special Risk Factors for Male Breast Cancer - Only approximately 1-1.5% of all breast cancer cases occur in men.- Several risk factors have been identified that make some men more likely to develop breast cancer than others.
These...
Bosentan receives positive EU opinion for treatment of patients with mildly symptomatic WHO functional Class I ALLSCHWIL, Switzerland - Actelion Ltd (SWX: ATLN) announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), issued a positive opinion for bosentan ...
Alkermes presents encouraging data on molecules targeting opioid receptors Data from two preclinical studies demonstrated that the three molecules showed statistically superior oral efficacy as well as evidence for improved metabolic and pharmacokinetic profiles compared to an active control.The study results...
Hot paper in Gene Expression: Caution: RNAi Biophoto Associates / Photo Researchers, Inc.Grimm et al., 'Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways,' Nature, 441:537-41, 2006.
(Cited in 147 papers) While studying the potential of RNA...
Fatty Liver Disease Ups Heart Risks for Obese Kids MONDAY, June 30 (HealthDay News) More than 6 million children in the United States have a condition called nonalcoholic fatty liver disease (NAFLD), which can boost their odds for heart disease, researchers report.NAFLD results from...
Study Strengthens Evidence of Link Between Liver Cancer and Diabetes The University of Texas M.Anderson Cancer Center SEATTLE-Diabetics may face three times the risk of liver cancer, according to data from a new study.
A number of epidemiological studies have 'suggested a relationship between some...
TopAbstracts in Cirrhosis 07/01/2008 TopAbstracts in Cirrhosis are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 28 days.Over 2000 peer-reviewed...
New oral angiogenesis inhibitor offers nontoxic therapy for cancers Because it is nontoxic and can be taken orally, the drug, called Lodamin, may be useful as a preventive therapy for patients at high risk for cancer or as a chronic maintenance therapy for a variety of cancers, preventing tumors from forming...
New Oral Angiogenesis Inhibitor Offers Potential Nontoxic Therapy for a Wide Range of Cancers BIOTECHNOLOGY, NANOTECHNOLOGY, ANGIOGENESIS, CANCER, MACULAR DEGENERATION, RMACEUTICALS, DRUGS Contact Information Available for logged-in reporters only Description The first oral, broad-spectrum angiogenesis inhibitor, specially formulated...
Metabasis to Present at the Collins Stewart 4th Annual Growth Conference SAN DIEGO-- (BUSINESS WIRE) -- Metabasis Therapeutics (Nasdaq: MBRX), announced today that Dr.Paul Laikind, president and chief executive officer, will present at the Collins Stewart 4th Annual Growth Conference at the Mandarin Oriental...
Liver Drug May Help Exhausted SpacewalkersSpacehab Eyes Biomedical Research Opportunities Aboard ISSGPS Inaccu Future astronauts might better endure exhausting spacewalks with the help of a handy liver drug.The drug captures free radical molecules produced during heavy exercise that could damage muscle tissue and cause fatigue for...
Raising your Good Cholesterol By Dr.Ray Strand Raising Your HDL or 'Good' Cholesterol by: Dr.
Ray Strand Physicians have known for years that those patients who have a high HDL or good cholesterol have a significantly decreased risk of developing coronary artery...
Alkermes presents encouraging data on molecules targeting opioid receptors Alkermes has announced positive preclinical results for three proprietary molecules targeting opioid receptors, including ALKS 33.Data from two preclinical studies demonstrated that the three molecules showed statistically superior oral...
Alkermes Presents Positive Data on Proprietary Molecules Targeting Opioid Receptors - Alkermes, Inc.(NASDAQ: ALKS) today announced positive preclinical results for three proprietary molecules targeting opioid receptors, including ALKS 33.
Data from two preclinical studies demonstrated that the three molecules showed...
Alkermes presents encouraging data on molecules targeting opioid receptors Data from two preclinical studies demonstrated that the three molecules showed statistically superior oral efficacy as well as evidence for improved metabolic and pharmacokinetic profiles compared to an active control.The study results...
Entecavir therapy for lamivudine-refractory chronic hepatitis B: Improved virologic, biochemical, and serology Hepatitis B Articles (HBV) Back  Entecavir therapy for lamivudine-refractory chronic hepatitis B: Improved virologic, biochemical, and serology outcomes through 96 weeks Hepatology July 1, 2008 Morris Sherman 1 *, Cihan Yurdaydin 2,...
Fatty Liver Disease Portends Heart Risk in Obese Kids SAN DIEGO, July 1 -- Fatty liver disease in overweight and obese children may be a harbinger of cardiovascular disease, particularly among those with metabolic syndrome, researchers said.Such children with nonalcoholic fatty ...
Fourth Annual Symposium on Liver-Directed Microsphere Therapy Raises Awareness of the Latest Advances for Trea More than 170 physicians and health care professionals specializing in the treatment of liver metastases gathered May 2-3 in Chicago for the fourth annual clinical symposium on liver -directed microsphere therapy.The symposium,...
